[Product Introduction]
Apalutamide (ALSO Translated As: Apalutamide) is a seacond-Generation Non-Word Receptor (AR) Inchibitor, Which Can Effec TVELY Prevent Androgen from Binding to the RecePTOR and Prevent AR it Transfers to the Nucleus of Tumor Cells and Plays The role of inhibiting androgen to promote the growth of tumor cells.
[Indications]
It is suitable for the treatment of non-metastatic castration-resistant prostate cancer (NM-CRPC), metastatic castration-sensitive prostate cancer (mCSPC), metastatic hormone-sensitive prostate cancer (mHSPC) and castration-resistant prostate cancer with High risk of metastasis. Adult patients with potential-sensitive prostate cancer (CSPC).
[Usage and Dosage]
The recommended dose is 240 mg (4 60 mg tablets), once a day, orally.
Tablets to be swallowed whole, either alone or with food.
If you miss a dose, you should take the medicine as soon as possible on the same day, and take the medicine according to the normal plan the next day. Do not take an extra dose of this product to make up for a missed dose.
Dose adjustment:
If the patient experiences ≥Grade 3 toxicity or intolerable adverse reactions, the drug should be suspended until the symptoms improve to ≤Grade 1 or the original grade, and if necessary, the same dose or a reduced dose (180 mg or 120 mg).
商品評價
目前沒有評價。